Target intelligence / Profile preview

Medium-chain triglyceride (MCT)

Target
MCT
Molecular classification
Other (lipid, dietary fat, not a protein target, not a receptor, enzyme, transporter, etc.)
01

Overview

Medium-chain triglyceride is a type of dietary fat comprised of three medium-chain fatty acids (chain lengths of 6–12 carbons) esterified to glycerol[5][8][1]. Unlike long-chain triglycerides, MCTs are rapidly hydrolyzed and absorbed through the gastrointestinal tract, entering the portal circulation directly, and transported to the liver. There, they undergo β-oxidation to generate acetyl-CoA, which may be used for rapid energy or converted to ketone bodies, providing an alternative energy source for the brain and other tissues, especially during carbohydrate restriction[1][2][3][8]. MCTs are widely used as nutritional supplements in disorders of fat malabsorption, as fuel for ketogenic diets, and in emerging research for neurodegenerative and metabolic syndromes. They are not considered drug targets; rather, their effects result from metabolic and signaling processes following ingestion.

Other names
Medium-chain triglyceridesMCT oilMCTsTriglycerides of medium-chain fatty acids
02

Mechanism of action

For nutritional/pharmaceutical use, the mechanism involves: Rapid hydrolysis of MCTs to medium-chain fatty acids, which are absorbed directly into the portal vein and transported to the liver for β-oxidation to produce acetyl-CoA (energy substrate) and ketone bodies; Activation of signaling pathways (Akt and AMPK), increasing energy expenditure, glucose uptake, and mitochondrial metabolism; Promotion of satiety via GLP-1 activation, inhibition of fat synthesis, and indirect appetite suppression.

03

Biological functions

Rapid energy substrate for tissues, especially liverPrecursor for ketone body formationModulator of mitochondrial activity and biogenesisMay influence gene expression and metabolism via signaling pathways (Akt, AMPK, PPAR)Can enhance lipid oxidation and may increase satietyMinor role in membrane structure
04

Disease associations

Used as an energy source in malabsorption syndromes and some gastrointestinal disordersTherapeutic adjunct in conditions requiring ketogenic diet (such as epilepsy and seizure disorders)Proposed for weight management, obesity, metabolic syndromePotential neuroprotective effects in Alzheimer’s disease and mild cognitive impairment (MCI)Used in treatment of cachexia or wasting syndromeInvestigated for athletic performance
05

Safety considerations

Gastrointestinal intolerance (diarrhea, cramps) when consumed in excessMay cause elevations in triglycerides in some patients (particularly with long-term/parenteral use)No significant toxicity at recommended doses, but data on long-term use are limitedNot recommended for people with liver failure due to rapid hepatic metabolism
06

Biomarkers

None are specific to MCTs as a target, but increased plasma ketone bodies may be used to monitor efficacy in ketogenic diets or cognitive conditionsPlasma ketones (as indirect biomarker of MCT metabolism)

Beyond the preview

Go deeper on Medium-chain triglyceride (MCT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medium-chain triglyceride (MCT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call